Drug Type Small molecule drug |
Synonyms NSC-732011, SR-16137, SR-16157 |
Target |
Mechanism ERα antagonists(Estrogen receptor alpha antagonists), ERβ modulators(Estrogen receptor beta modulators), STS inhibitors(Steryl-sulfatase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H44N2O4S |
InChIKeyASNNHMZDKNSENI-FYUXVVBBSA-N |
CAS Registry943344-76-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | US | 01 May 2004 |